SCR-LIP-000152 · Claim · machine-readable JSON →

This review reports that lipedema subcutaneous adipose tissue exhibits a 'healthy expansion' phenotype with preserved insulin sensitivity (48% higher in obese lipedema patients), lower HbA1c (5.55% vs 6.73%), low diabetes prevalence (~5%) and dyslipidemia (~7%) despite elevated BMI, alongside anti-inflammatory M2 macrophage predominance in thigh fat.

Created: 2026-05-31 · Last updated: 2026-05-31

Auto-compiled by the Layer 1 surveillance loop; not yet human-reviewed. anthropic/claude-opus-4.8 · 2026-05-31

Evidence over time

Evidence (1)

• Lipedema and adipose tissue: current understanding, controversies, and future directions — Rabiee (2025) — supporting · review · 2025
  Narrative review synthesizing evidence that lipedema's peripheral/gynoid fat shows a metabolically favorable profile (preserved insulin sensitivity, low diabetes/dyslipidemia prevalence, anti-inflammatory M2 bias), which supports the affirm

Context (PECO)

Answers these questions

• Does a lipedema-like (peripheral/gynoid) fat distribution protect against cancer or metabolic disease? supporting

Gaps & caveats

Auto-ingested single source; not yet human-reviewed.

Change log

• 2026-05-31 — created

← All claims